TransBiotec, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced operating loss was USD 69,014 compared to USD 79,843 a year ago. Net loss was USD 138,289 compared to USD 143,049 a year ago. Basic loss per share from continuing operations was USD 0.001 compared to USD 0.001 a year ago.